OverviewChartNewsTraderScreen

Soc. Generale Knock-Out AMD 17.05.../  DE000SU7E903  /

Frankfurt Zert./SG
2024-05-08  9:46:42 PM Chg.-0.030 Bid9:59:57 PM Ask- Underlying Strike price Expiration date Option type
9.340EUR -0.32% 9.410
Bid Size: 1,000		 -
Ask Size: -		 Advanced Micro Devic... - USD 2024-05-17 Call
GlobeNewswire 05-08 Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference
GlobeNewswire 05-08 Alkeus Pharmaceuticals Announces Positive Interim Results Demonstrating No Signs of Disease Progress...
GlobeNewswire 05-08 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire 05-08 AMD Receives IEEE 2024 Corporate Innovation Award for Leadership in Chiplet Design for High-Performa...
GlobeNewswire 05-08 Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
GlobeNewswire 05-08 EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporat...
GlobeNewswire 05-07 Ocular Therapeutix™ Reports First Quarter 2024 Results
GlobeNewswire 05-07 Optiver Chooses AMD Enterprise Portfolio to Power its Data Center Modernization, Enabling New Era of...
GlobeNewswire 05-07 Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results
GlobeNewswire 05-07 Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 05-06 Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMD
GlobeNewswire 05-06 Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease ...
GlobeNewswire 05-06 Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...
GlobeNewswire 05-06 Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
GlobeNewswire 05-06 EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Prol...
GlobeNewswire 05-03 Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024
GlobeNewswire 05-03 YieldMax™ ETFs Announces Monthly Distributions on CONY (109.51%), MSTY (103.22%), NFLY (67.74%), SQY...
GlobeNewswire 05-02 Outlook Therapeutics® to Present at the Retina World Congress 2024
GlobeNewswire 05-02 Kriya Announces Three Presentations at the 2024 Association for Research in Vision and Ophthalmology...
GlobeNewswire 05-02 YieldMax™ Launches Short TSLA Option Income Strategy ETF CRSH
GlobeNewswire 05-01 Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...
GlobeNewswire 05-01 Gene Therapies in Degenerative Retinal Disease Hold Potential to Capture Significant Portion of Mark...
TeleTrader 05-01 AI-related stocks plunge, Super Micro leads with 17% decline
GlobeNewswire 05-01 Micron First to Ship Critical Memory for AI Data Centers
GlobeNewswire 05-01 Alkeus Pharmaceuticals Announces Presentation of Positive Gildeuretinol Data in Early-Stage Stargard...